The Board has remanded the case due to insufficient development of evidence regarding service connection for renal cell carcinoma, which is claimed as secondary to herbicide exposure. The Veteran's hypertension and obesity are also being evaluated in relation to this claim.
The deciding factor: The Board found that the prior opinion did not address the specific questions posed by the remand directives and provided a conflicting rationale.
- Claimed conditions
- renal cell carcinoma
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- October 28, 2020
- Citation
- 20069787
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied the veteran's claim for service connection for renal cell carcinoma, finding that the evidence does not support a link between the condition and her military service.
- Granted
The Board granted SMC based on the need for regular aid and attendance due to the Veteran's service-connected renal cell carcinoma.
- Granted
The Board granted service connection for renal cell carcinoma, finding that it was due to the Veteran's service-connected hypertension.
- Denied
The Board denied service connection for the cause of the Veteran's death, finding that his causes of death were not related to his military service.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.